• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Asthma
  • Atrial Fibrillation
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

2010 may be the year for Healthcare IPOs


The stars may be aligning for healthcare initial public offerings (IPOs) in 2010.

According to a recent Reuters news article, the stars may be aligning for healthcare initial public offerings (IPOs) in 2010. Not only are investors expected to take on more risk as the economic outlook improves, but there is potential for the healthcare bill to provide money to the industry.

While the final version of the new health legislation is not yet known, it is unlikely that it would immediately mean more IPOs. However, its passage could be a taken as a sign of stability that would increase the attractiveness of the sector for investors.

According to the article, the heads of a number of equity capital markets said they expected healthcare to produce more IPOs in 2010.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.